!!Topics - Clinical Nephrology Update

Ø  Monoclonal gammopathies and kidney/spectrum of kidney diseases in MM Ø  Membranoproliferative Glomerulonephritis new aspects and classification Ø  Update in Lupus Nephritis Ø  Crescentic glomerulonephritis and vasculitis Ø  Podocytopathies Ø  Membranous nephropathy, current diagnostic tools and new therapeutic

strategies Ø  Henoch-Schoenlein Syndrome and IgA nephropathy Ø  New Biologics for Glomerular diseases Ø  Thrombotic microangiopathy and Hemolytic Uremic Syndrome Ø  Glucosylceramides and kidney disease Ø  Recurrent glomerulopathy after kidney transplant: update Ø  Overview of Acid-Base and electrolyte management

!!Confirmed Speakers

Ø  Prof. Fernando Fervenza, Director of the Nephrology Collaborative Group, Mayo Clinic

Ø  Prof. Nelson Leung, Nephrology, and Hypertension, Mayo Clinic. International Kidney and Monoclonal Gammopathy Research Group

Ø  Prof. Ulrich Specks, Chair, Division of Pulmonary & Critical Care Medicine, Mayo Clinic

Ø  Prof. Brad Rovin, Director of The Ohio State University’s Division of Nephrology Ø  Prof. Sanjeev Sethi, Laboratory Medicine and Pathology, Mayo Clinic Ø  Prof. Haterrm Amer, Medical Director Reconstructive Transplant Program, Mayo

Clinic Ø  Prof. Alberto Ortiz, Chief of Nephrology, Fundacion Jimenez Diaz & Professor of

Medicine, University Autonoma of Madrid Ø  Prof. Manuel Praga, Nephrology, Hospital Universitario 12 de Octubre, Madrid Ø  Prof. Biff Palmer, Internal Medicine at UT Southwestern Medical Center, Dallas,

Texas Ø  Prof. Vicente Torres, Nephrology and Hypertension, Mayo Clinic Ø  Prof. Debora Clegg, Cedars-Sinai Division of General Internal Medicine and

Department of Biomedical Sciences Ø  Prof. Fernando Cosio, Transplant Nephrology, Mayo Clinic

!!

Meeting Attendees Will Be Able To:

u Review pathophysiologic aspects of principal kidney diseases

u Discuss the current diagnosis tools in nephropathies

u Review new management strategies of kidney damage associated

with systemic diseases

u Summarize data from the current trials on treatment primary and

secondary kidney diseases

u Define pathologic manifestations, diagnosis, and challenges of

managing various primary and secondary kidney diseases.

u Appraise recent publications related to all topics addressed

u Recognize new biologics for glomerulopathies

u Integrate recent treatment strategies for ANCA vasculitis, Myeloma

ADPKD and Lupus nephropathy in their practice

u Identify strategies for recurrence of glomerulopathies in transplant

!

Who  should  a*end?  

   

This  ac(vity  is  designed  for  nephrologists,  fellows,  internists,  and  other  prac(cing  

health  care  professionals,  who  desire  an  update  on  pathogenesis  and  treatment  of  

kidney  diseases.  

Through  a  combina(on  of  lectures,  literature  review,  and  case-­‐based  presenta(ons,  

this  mee(ng  will  deliver  up-­‐to-­‐date  and  cu=ng  edge  informa(on  that  can  be  

directly  integrated  into  clinical  prac(ce.  

 

!

Lunch  (me  12:30  

8:30 9:00 9:30 10:00 10:15 10:45 11:15 11:45

14:00 14:45 15:30 16:15 16:30 17:15 18:00

Coffee  break  

conference

conference conference

conference conference

cases

Coffee  break  

conference

conference conference

conference conference

cases

Preliminary conference schedule

Coffee  break  

Discussion

conference

conference

conference

conference

conference

Coffee  break  

Discussion

conference

conference

conference

conference

conference

Venue to be confirmed

Scientific Committee: F Fervenza, K Soto, S Sethi, F

Carvalho

Organizer Committee: P Correia, B Rodrigues, P

Carrilho, L Inchaustegui, A Serra

Management team: P Campos, F Pereira, J Cassis, L

Cunha

Organization Mayo Clinic & Hospital Fernando Fonseca & Grupo

de Nefropatologia de Lisboa

Chairmen: K Soto and F Fervenza